Agios Pharma (AGIO) Announces Submission of AG-221 NDA to FDA by Celgene (CELG)
Tweet Send to a Friend
Agios Pharma (NASDAQ: AGIO) disclosed the following in a U.S. SEC filing on Wednesday:Item 7.01 Regulation FD Disclosure.Agios Pharmaceuticals, Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
